Duration: 4-8 weeks

Peptides in This Stack

Peptide Dose Frequency Route Notes
Thymosin Alpha-1 1.6 mg 2x/week subcutaneous Used clinically for immune modulation; well-studied safety profile
LL-37 50-100 mcg 1x/day subcutaneous Antimicrobial peptide; can also be used short-term at higher doses

Protocols shown are for informational purposes only. Consult a healthcare provider before starting any peptide protocol.

About This Stack

A dual-action immune stack combining adaptive and innate immune support. Thymosin Alpha-1 enhances T-cell function and is used clinically for immune deficiencies and chronic infections. LL-37 is a human cathelicidin with direct antimicrobial and immune-modulating properties.

Import This Stack

Add this stack to your PepStackr account. Track doses, manage inventory, set reminders, and visualize blood concentration levels.

Get Started Free

Common Questions

Is Thymosin Alpha-1 FDA approved?
Thymosin Alpha-1 (Zadaxin) is approved in over 30 countries for hepatitis B and as an immune adjuvant. It is not FDA approved in the US but has extensive clinical data.
Can I use this stack preventatively?
Many users run short cycles (4-8 weeks) during cold/flu season or when immune support is needed. Thymosin Alpha-1 is commonly used for ongoing immune modulation.

Related Stacks